Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

Robert Chen,1 Suzanne Allibone,2 Nancy L Bartlett,3 Pauline Brice,4 Andy Chen,5 Katrina Pose,6 Lynn Rich,7 Vijay Bonthapally,8 Phillip M Garfin,9 Michelle Fanale10 1Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA; 2The Lymphoma Service of the Chr...

Full description

Bibliographic Details
Main Authors: Chen R, Allibone S, Bartlett NL, Brice P, Chen A, Pose K, Rich L, Bonthapally V, Garfin PM, Fanale M
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:OncoTargets and Therapy
Subjects:
patient-reported outcomes
brentuximab vedotin
health-related quality of life
Hodgkin lymphoma
anaplastic large-cell lymphoma
Online Access:https://www.dovepress.com/patient-reported-outcomes-of-brentuximab-vedotin-in-hodgkin-lymphoma-a-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/patient-reported-outcomes-of-brentuximab-vedotin-in-hodgkin-lymphoma-a-peer-reviewed-article-OTT

Similar Items